Collaboration | Microbiota I-Center

We believe that collaboration is the key to unlocking the full potential of microbiome.
As such, we partner with leading clinician researchers and institutions, driving human microbiome research across the globe — from the United States to Australia and the United Kingdom.

細菌在我們身體

扮演什麼角色？

您的微生物組

來自哪裡？

Collaborators

Prof. Michael Kamm

Michael Kamm is Professor at the University of Melbourne, and Gastroenterologist at St Vincent’s Hospital Melbourne. He was previously Chairman of Medicine and Director of the Inflammatory Bowel Disease and Physiology Units at St Mark’s Hospital, the London specialist hospital for gut diseases, and Professor of Gastroenterology at Imperial College London. He returned home to Melbourne in 2008.

His main focus is on luminal gastroenterology. He is a passionate researcher, clinician and teacher. His research spans from basic science to clinical application, with a special interest in inflammatory bowel diseases and functional gut and pelvic floor disorders.

Prof. David Rubin

David T. Rubin is the Joseph B. Kirsner Professor of Medicine, Chief of the Section of Gastroenterology, Hepatology & Nutrition, and Director of the Inflammatory Bowel Disease Center at the University of Chicago Medicine. He earned a medical degree with honors at The University of Chicago Pritzker School of Medicine where he also completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics. He is associate faculty member at the MacLean Center for Clinical Medical Ethics, associate investigator at the University of Chicago Comprehensive Cancer Center and a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics. He is the chair of the National Scientific Advisory Committee of the Crohn’s & Colitis Foundation. He is the deputy chair of the Executive Committee of the International Organization for the Study of Inflammatory Bowel Disease.

Dr. Rubin twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), and in 2020, Dr. Rubin received the Sherman Prize for Excellence in Crohn’s and Colitis. He is an Associate Editor of the journal Gastroenterology and Editor-in-Chief of the ACG On-Line Education Universe. Dr. Rubin is an editor of Curbside Consultation in IBD (3rd ed), senior editor of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease (12th ed), and an author on >500 articles on management of IBD, including the 2019 ACG Guidelines for ulcerative colitis.

Prof. Eugene Chang

Dr. Eugene B. Chang is a physician-scientist, the Martin Boyer Distinguished Professor of Medicine, and the Director of the Microbiome Medicine Program at the University of Chicago. He leads a large, multi-disciplinary group of basic, translational, and clinical investigators in studies of host-microbe interactions and disease mechanisms of the gut in states of health and disease (primarily complex immune disorders like inflammatory bowel diseases and metabolic disorders like obesity and metabolic syndrome). These studies have been supported through several NIH grants and involve team science collaborations with colleagues from multi-disciplinary backgrounds.

Industry

We believe that collaboration is the key to unlocking the full potential of microbiome. As such, we partner with leading clinician researchers and institutions, driving human microbiome research across the globe — from the United States to Australia and the United Kingdom.

We believe that collaboration is the key to unlocking the full potential of microbiome.
As such, we partner with leading clinician researchers and institutions, driving human microbiome research across the globe — from the United States to Australia and the United Kingdom.